Search
- Dec 10, 2023
Mass General's Marcela Maus talks about the latest in cell therapy at #ASH23
Dr. Maus comments on CD19 lupus data, the recent FDA note on malignancies, and the work her lab is doing for brain and heme cancers.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A